Company profilePharmaceutical#562 of 1,318 in Pakistan1 DRAP alert

ALCON SCIENTIFIC SERVICE.

Pharmaceutical company · 22 brands · 31 molecules

Ranked #30 of 50 companies in Anti-Infective, Ophthalmologicals

22 registered products 19 pharmaceutical brands 31 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

ALCON SCIENTIFIC SERVICE. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 22 product registrations across 31 distinct molecules. Its portfolio is concentrated in Anti-Infective, Ophthalmologicals and Antiglaucoma Preparations And Miotics. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Eye5 brands

Benzalkonium3 brands

Naphazoline3 brands

Tobramycin2 brands

Hydroxypropyl Methylcellulose2 brands

Pheniramine2 brands

Dexamethasone2 brands

Moxifloxacin1 brand

Dextran1 brand

Carbachol1 brand

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DVAGO1 products · Rs 202.49 – Rs 202.49

Servaid1 products · Rs 765 – Rs 765

Median across source: Rs 765

Regulatory record

1 alert in the DRAP feed we track.

Falsified Vigamox® Ophthalmic Solution – Batch VHF02A (Not from Authorized Source)

2025-09-17

Competitive set

Companies whose registered portfolio overlaps most with this one.

Sante (Private) Limited15 shared molecules

REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD.13 shared molecules

Atco Pharma International (Pvt) Ltd12 shared molecules

INNVOTEK PHARMACEUTICALS12 shared molecules

HIMONT PHARMACEUTICALS (PVT) LTD.10 shared molecules

Medipak (Pvt) Ltd10 shared molecules

ETHICAL LABORATORIES PRIVATE LIMITED10 shared molecules

Barrett Hodgson Pakistan (Private) Ltd.9 shared molecules

Novartis Pharmaceuticals (Pvt) Ltd.9 shared molecules

ALZA Pharma9 shared molecules

Get the full profile for ALCON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included